Skip to main content

Table 1 Characteristics of 50 patients with nasopharyngeal carcinoma

From: Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma

Characteristics   Overall CD80/86(+)
   No. % No. %
Age, years
  Range 38–83   38–78  
  Median 50   46  
  Mean 53   50  
Sex
  Male 42 84 10 91
  Female 8 16 1 9
Pathology (WHO classification)
  Type I --   --  
  Type II 35 70 6 55
  Type III 15 30 5 45
T Stage (1997 AJCC)
  T1 or T2 32 64 9 82
  T3 or T4 18 36 2 18
N Stage (1997AJCC)
  N0 or N1 24 48 6 55
  N2 17 34 3 27
  N3 9 18 2 18
Overall Stage (1997 AJCC)
  I 5 10 3 27
  II 10 20 3 27
  III 13 26 2 18
  IV 22 44 3 27
Treatment
  Radiotherapy alone 8 16 2 18
  Concurrent Chemoradiotherapy 42 84 9 82
Status
  Death 16 32 0 0
  Alive 34 68 11 100
  1. Abbreviations: WHO, World Health Organization; AJCC, American Joint Committee on Cancer; FDRC, Follicular Dendritic Reticulum Cells
\